D. Boral Capital

I'm excited to announce that I will be the keynote speaker at the Inaugural D. Boral Capital (DBC) Conference, which will be held on May 14, 2025, at The Plaza Hotel in New York City. This premier event will bring together top executives from public and private companies, institutional investors, high-net-worth individuals, and corporate clients across various sectors. If you're interested in attending or learning more about sponsorship opportunities, please visit www.dboralcapital.com for further information. #DBoralCapital #InauguralDBCConference2025 #InvestmentBanking

D. Boral Capital served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering. We would like to thank the issuer, Park Ha Biological Technology Co., Ltd., issuer counsel Ortoli | Rosenstadt LLP, and D. Boral Capital’s counsel, Hunter Taubman Fischer & Li LLC. Additionally, we would like to thank Stephanie Hu, Partner and Co-Head of Investment Banking and Ryan Zhang, Vice President at D. Boral Capital, for their collaboration on this significant transaction. Press Release: https://lnkd.in/e4f4wfzU Visit our website to learn more about recent transactions: 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #PHH #TransactionAnnouncement #InvestmentBanking

Happy New Year! As we bid farewell to 2024, we at D. Boral Capital extend our heartfelt wishes for a prosperous New Year.🎉 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #HappyHolidays #HappyNewYear

D. Boral Capital served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Private Placement. We would like to thank the issuer, FibroBiologics (Nasdaq: FBLG), CEO Pete O'Heeron, CFO Robert E Hoffman, General Counsel Ruben A. Garcia, issuer counsel, Norton Rose Fulbright, D. Boral Capital's counsel, Winston & Strawn LLP, and Senior Managing Director David Lee, for their collaboration on this significant transaction. Press Release: https://lnkd.in/eNuTyc7B Visit our website to learn more about recent transactions: 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #FBLG #TransactionAnnouncement #InvestmentBanking

Happy Hanukkah from all of us at D. Boral Capital. As the Festival of Lights begins, we extend our warmest wishes to our clients, partners, and associates who celebrate this joyous holiday. 🕎 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #HappyHolidays #HappyHanukkah

Merry Christmas from all of us at D. Boral Capital.🎄 We extend our warmest wishes to our valued clients, partners, and associates during this holiday season. 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #HappyHolidays #MerryChristmas

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on Omeros Corp. (Nasdaq: OMER). This coverage reflects our commitment to providing in-depth analysis of promising companies in the healthcare industry. 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #OMER

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on Compass Therapeutics, Inc. (Nasdaq: CMPX). This coverage reflects our commitment to providing in-depth analysis of promising companies in the healthcare industry. 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #CMPX

D. Boral Capital is pleased to highlight our Vice President of Equity Research, Jesse Sobelson’s continued coverage on Rezolve AI Ltd (Nasdaq: RZLV). This coverage reflects our commitment to providing in-depth analysis of promising companies focused on developing AI-enabled solutions in the Software and Services industry. 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #RZLV

D. Boral Capital served as Exclusive Placement Agent to Webuy Global Ltd. (Nasdaq: WBUY) in connection with its $3.7 Million Registered Direct Offering. We would like to thank the issuer, WEBUY, CEO Vincent Xue Bin, CFO Catherine Phang, issuer counsel Ortoli | Rosenstadt LLP, and Placement Agent counsel, Hunter Taubman Fischer & Li LLC. Additionally, we would like to thank Stephanie Hu, Partner and Co-Head of Investment Banking at D. Boral Capital, for her collaboration on this significant transaction. Press Release: https://lnkd.in/giTN2fKm Visit our website to learn more about recent transactions: 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #WBUY #TransactionAnnouncement #InvestmentBanking